Spruce Biosciences, Inc.
SPRB
$52.64
$2.875.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 2,928.60% | -30.10% | -108.37% | -23.54% | -105.32% |
| Gross Profit | -2,928.60% | 30.10% | 108.65% | 15.81% | 106.64% |
| SG&A Expenses | 39.30% | 20.71% | 50.75% | -6.89% | -12.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 513.37% | -17.29% | -87.08% | -17.79% | -76.88% |
| Operating Income | -513.37% | 17.29% | 86.71% | 12.53% | 73.18% |
| Income Before Tax | -685.15% | 12.64% | 37.83% | 5.29% | 77.49% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -685.15% | 12.64% | 37.83% | 5.29% | 77.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -685.15% | 12.64% | 37.83% | 5.29% | 77.49% |
| EBIT | -513.37% | 17.29% | 86.71% | 12.53% | 73.18% |
| EBITDA | -491.47% | 18.99% | 86.72% | 12.47% | 73.21% |
| EPS Basic | -90.91% | 62.68% | 73.50% | 7.38% | 79.10% |
| Normalized Basic EPS | -90.92% | 62.68% | 87.79% | 7.38% | 79.10% |
| EPS Diluted | -90.91% | 62.68% | 73.50% | 7.38% | 79.10% |
| Normalized Diluted EPS | -90.92% | 62.68% | 87.79% | 7.38% | 79.10% |
| Average Basic Shares Outstanding | 311.28% | 134.11% | 134.60% | 2.27% | 7.71% |
| Average Diluted Shares Outstanding | 311.28% | 134.11% | 134.60% | 2.27% | 7.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |